The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Ann-Margaret.Little@glasgow.ac.uk
Histocompatibility and Immunogenetics Lab, Laboratory Medicine Building, Gartnavel General Hospital, Glasgow, G12 0ZD
Rennie, T. J. W. et al. (2022) Comparison of kidney transplant outcomes in HLA compatible and incompatible transplantation: a national cohort study. Nephrology, 27(12), pp. 962-972. (doi: 10.1111/nep.14102) (PMID:36028988)
Little, A.-M. et al. (2021) BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation. International Journal of Immunogenetics, 48(2), pp. 75-109. (doi: 10.1111/iji.12527) (PMID:33565720)
McGuinness, D. et al. (2016) Identification of molecular markers of delayed graft function based on the regulation of biological ageing. PLoS ONE, 11(1), e0146378. (doi: 10.1371/journal.pone.0146378) (PMID:26734715) (PMCID:PMC4703336)
Johnson, P. C.D. et al. (2015) Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. International Journal of Cancer, 137(5), pp. 1066-1075. (doi: 10.1002/ijc.29467) (PMID:25648508) (PMCID:PMC4737225)
Burt, C., Parker, A., McQuaker, G., Copland, M. , Brierley, C., Little, A. and Clark, A. (2014) In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors. Bone Marrow Transplantation, 49(5), pp. 657-663. (doi: 10.1038/bmt.2014.8)
Sanchez-Mazas, A. et al. (2012) Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. International Journal of Immunogenetics, 39(6), pp. 459-476. (doi: 10.1111/j.1744-313X.2012.01113.x)
Rennie, T. J. W. et al. (2022) Comparison of kidney transplant outcomes in HLA compatible and incompatible transplantation: a national cohort study. Nephrology, 27(12), pp. 962-972. (doi: 10.1111/nep.14102) (PMID:36028988)
Little, A.-M. et al. (2021) BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation. International Journal of Immunogenetics, 48(2), pp. 75-109. (doi: 10.1111/iji.12527) (PMID:33565720)
McGuinness, D. et al. (2016) Identification of molecular markers of delayed graft function based on the regulation of biological ageing. PLoS ONE, 11(1), e0146378. (doi: 10.1371/journal.pone.0146378) (PMID:26734715) (PMCID:PMC4703336)
Johnson, P. C.D. et al. (2015) Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. International Journal of Cancer, 137(5), pp. 1066-1075. (doi: 10.1002/ijc.29467) (PMID:25648508) (PMCID:PMC4737225)
Burt, C., Parker, A., McQuaker, G., Copland, M. , Brierley, C., Little, A. and Clark, A. (2014) In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors. Bone Marrow Transplantation, 49(5), pp. 657-663. (doi: 10.1038/bmt.2014.8)
Sanchez-Mazas, A. et al. (2012) Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. International Journal of Immunogenetics, 39(6), pp. 459-476. (doi: 10.1111/j.1744-313X.2012.01113.x)